Neurologist and author Daniel Gibbs, PhD, joins the podcast to discuss his recent book, “A Tattoo on My Brain,” which details his journey from treating Alzheimer’s disease clinically for 25 years to being diagnosed with early-stage Alzheimer’s. Dr. Gibbs discusses early signs he experienced and daily life with the disease, as well as thoughts on the recent FDA-approved treatment aducanumab (marketed as Aduhelm).
Guest: Daniel Gibbs, PhD, neurologist
Episode TopicsWhat inspired the title of your book, “A Tattoo on the Brain”? 1:01
What were these early signs of Alzheimer's disease that you recognized in yourself? 3:42
What were your impressions of the clinic process, and where is there room for improvement? 8:08
Can you share your view on family history? 9:17
What do you say to people about direct-to-consumer genetic testing, both as a recipient and as a clinician? 10:57
Did knowing your risk of Alzheimer's disease help or harm you? 12:42
Did you find any habit difficult to incorporate into your day? 13:17
How important was it for you to be involved in research and what did you gain from being a research participant? 17:15
How do you feel about the recent FDA approval of aducanumab for clinical use? 20:25
As a patient, would you sign up for this drug, and if you were still working as a neurologist, would you prescribe this drug? 22:59
How do you find the balance between enjoying daily life and engaging proactive activities meant to improve the future? 24:49
How can we reframe the way people understand Alzheimer's disease? 28:18
Was it difficult to publicly discuss your experience, and what have you learned from this process? 29:52
What do you hope the reader takes away from your book? 31:15
Find Dementia Matters online
Follow us on Facebook
Follow us on Twitter
Study Shows Do-Not-Resuscitate Orders Can Lead to Worse Care, Increase Death Rates
‘Finding the Right Words’: Author Interview with Cindy Weinstein and Bruce Miller
Alcohol and the Brain: One Drink a Day Associated with Brain Shrinkage
Women’s Health Month: Women and Alzheimer’s Disease
Disaggregating Racial Data: How Studying Ethnic Subgroups Can Improve Research
Incorporating Cultural Knowledge: Improving Alzheimer’s Disease Research for Veterans and Native Americans
Update on Blood Tests for Alzheimer’s Disease
Harnessing the Power of Autophagy to Treat Alzheimer’s Disease
Go with the (4D) Flow: Neuroimaging Technology Used to Study Overlap of Cerebrovascular Disease and Alzheimer’s
Breaking Down Medicare’s Proposed Decision on Aducanumab and Monoclonal Antibody Treatments
Nasal Vaccine for Alzheimer’s Disease Enters Clinical Trial
‘American Dementia’: Author Interview with Dr. Daniel George and Dr. Peter Whitehouse
New Research Shifts Thinking on Metabolism and Aging
Aging Behind the Wheel: How Driving Behavior Can Identify Preclinical Alzheimer’s Disease
Global Challenges in Dementia Diagnosis: A Deep Dive into ADI’s World Alzheimer’s Report 2021
Accessibility and Community: Bringing Alzheimer’s and Dementia Resources to the Latinx Community
You Are What You Eat: Study of Diet and Brain Health Shows Cognitive Benefits from Cheese, Wine and Lamb
AARP Study Shows Stigma Surrounding Dementia among Healthcare Professionals and General Public
Caregivers, Care Partners and People with Dementia: Brainstorming New Interventions for Dementia Care
Tackling Stigma and Alzheimer’s Disease within the AAPI Community
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks